Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18847-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#18847-1-AP, RRID:AB_10598163
- Product name
- IRF2BP2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated IRF2BP2 antibody (Cat. #18847-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Identification of proximal SUMO-dependent interactors using SUMO-ID.
IRF2BP2 prevents ox-LDL-induced inflammation and EMT in endothelial cells via regulation of KLF2.
Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling.
Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors.
The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.
Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen.
Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.
Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2).
Barroso-Gomila O, Trulsson F, Muratore V, Canosa I, Merino-Cacho L, Cortazar AR, Pérez C, Azkargorta M, Iloro I, Carracedo A, Aransay AM, Elortza F, Mayor U, Vertegaal ACO, Barrio R, Sutherland JD
Nature communications 2021 Nov 18;12(1):6671
Nature communications 2021 Nov 18;12(1):6671
IRF2BP2 prevents ox-LDL-induced inflammation and EMT in endothelial cells via regulation of KLF2.
Jiang Y, Shen Q
Experimental and therapeutic medicine 2021 May;21(5):481
Experimental and therapeutic medicine 2021 May;21(5):481
Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling.
Barysch SV, Stankovic-Valentin N, Miedema T, Karaca S, Doppel J, Nait Achour T, Vasudeva A, Wolf L, Sticht C, Urlaub H, Melchior F
EMBO reports 2021 Mar 3;22(3):e49651
EMBO reports 2021 Mar 3;22(3):e49651
Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors.
Schleicher EM, Dhoonmoon A, Jackson LM, Clements KE, Stump CL, Nicolae CM, Moldovan GL
PLoS genetics 2020 Nov;16(11):e1009176
PLoS genetics 2020 Nov;16(11):e1009176
The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.
Feng X, Lu T, Li J, Yang R, Hu L, Ye Y, Mao F, He L, Xu J, Wang Z, Liu Y, Zhang Y, Ji H, Zhao Y, Cheng S, Tian W, Zhang L
Hepatology (Baltimore, Md.) 2020 Jun;71(6):1988-2004
Hepatology (Baltimore, Md.) 2020 Jun;71(6):1988-2004
Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen.
Chachami G, Stankovic-Valentin N, Karagiota A, Basagianni A, Plessmann U, Urlaub H, Melchior F, Simos G
Molecular & cellular proteomics : MCP 2019 Jun;18(6):1197-1209
Molecular & cellular proteomics : MCP 2019 Jun;18(6):1197-1209
Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.
Yao Y, Wang Y, Li L, Xiang X, Li J, Chen J, Liu Z, Huang S, Xiong J, Deng J
Journal of cellular and molecular medicine 2019 Dec;23(12):8076-8089
Journal of cellular and molecular medicine 2019 Dec;23(12):8076-8089
Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2).
Fang J, Li T, Zhu X, Deng KQ, Ji YX, Fang C, Zhang XJ, Guo JH, Zhang P, Li H, Wei X
Hypertension (Dallas, Tex. : 1979) 2017 Sep;70(3):515-523
Hypertension (Dallas, Tex. : 1979) 2017 Sep;70(3):515-523
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 18847-1-AP(IRF2BP2 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-IRF2BP2 (IP:18847-1-AP, 3ug; Detection:18847-1-AP 1:500) with K-562 cells lysate 2400ug.
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The IRF2BP2 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human IRF2BP2. This antibody recognizes human, mouse antigen. The IRF2BP2 antibody has been validated for the following applications: ELISA, WB, IHC, IP analysis.